Skip to content
Search AI Powered

Latest Stories

New York Cannabis: Who Deserves to Pay to Play?

New York's medical cannabis MSOs want in on the adult-use market, but...
New York's medical cannabis MSOs want in on the adult-use market, but...

Article by Frederika Easley, Director of Strategic Initiatives, The People’s Ecosystem

New York’s medical cannabis MSOs want in on the adult-use market. The MRTA stipulates they pay an entrance fee. Regulators have yet to settle on the amount of the fee, however the MSOs are balking at the previously floated cost of $20 million.


Given the fluid state of things and in recognition of their leverage, the MSOs are lobbying for an amount that takes into account industry realities and the ability for payments to be gradual. 

None of this surprises me. We operate in a capitalist society, where everyone is trying to make a deal. 

Do MSOs Deserve Preferential Treatment in New York?

The MSOs believe that the investment they made, by being the first to step into New York’s regulated cannabis space, should afford them some preferential treatment. 

Now to be clear, their access to vertical licensure is pretty much exclusive except for the microbusiness license. Not to mention they’ve had over five years to plant their flags, establishing brand recognition and a loyal consumer base. 

But all of this is not without cost. 

Creating a vertical, seed-to-sale business was not simply an option it was mandated in New York’s medical cannabis laws. In fact, the original five, Bloomfield Industries (acquired by MedMen), Columbia Care, Etain, PharmaCann and Vireo Health, were required to do so within five months, which if you’ve tried to start any business you know that time flies quickly and to expedite progress additional funds are necessary. 

And so this idea that the MSOs deserve early access is understandable. I may not agree, specifically from a justice and equity standpoint, but I get it. 

Accountability is Everything in This Industry

But then we find stories like this lawsuit against MedMen for refusing to pay rent. MedMen owes close to a million dollars in rental fees on properties that they signed lease agreements for in New York and Chicago and have neglected to make good on. 

If MedMen is not following the rules of basic lease agreements, have they also skirted other rules and regulations? 

Frederika Easley

MedMen’s position is that because cannabis is still federally illegal they can not judicially be held accountable. 

This floored me! I thought well damn the audacity and privilege. Finding real estate for cannabis entrepreneurs is difficult and costly enough. Add to it the additional hurdles Black, LatinX, Indigenous people and women in general are facing. The residual impact of MedMen’s position is dangerous and can be costly. 

If MedMen is not following the rules of basic lease agreements, have they also skirted other rules and regulations? 

Are MSOs Following the Rules or Not?

Before we tackle timelines and price tags around MSOs accessing New York’s adult-use market, why don’t we first question compliance? Because maybe certain stakeholders should not be allowed to advance based on merit. 

Have all of the medical state operators maintained full compliance? Are they currently and have they been since the inception of license receival? 

To put it plainly, are they all fully vertical, as required by New York’s medical cannabis laws? Are they all current with tax payments? 

If they have received any citations based on physical location compliance checks, have they rectified those issues? 

These are important questions that require much-needed conversation and most importantly: action. 

To whom much is given much is required and even if you have the money to play, the question is do you deserve it!

Need a little more Bluntness in your life? Subscribe for our newsletter to stay in the loop.

More For You

How much are you paying for your weed?
How much are you paying for your weed?

FAQ: How Much Is A Gram Of Weed? An Ounce?

If you’re new to buying weed, one of the first things to learn is quantities. That’s because at a certain point, there are greater savings that come with buying higher quantities. 

Additionally, sometimes you find a favorite strain, and it’s only available in certain sizes. 

Keep ReadingShow less
Business of Cannabis: New York Conference
Business of Cannabis: New York Conference

Business of Cannabis: New York Conference Fuels Growth Amid Regulatory Challenges

As federal cannabis regulations in the United States are poised for relaxation, the cannabis industry is experiencing renewed vigor, and New York is at the forefront of this evolving landscape. 

The upcoming Business of Cannabis: New York conference, scheduled for November 3, 2023, in Williamsburg, Brooklyn, promises to be a pivotal event for investors, operators, and industry leaders. The conference aims to explore opportunities in New York's burgeoning adult-use cannabis market, which has faced unique challenges since legalization.

Keep ReadingShow less
If you want to work in cannabis, the role of budtender may be a good entry point.
If you want to work in cannabis, the role of budtender may be a good entry point.

How to Become a Budtender in 2022

Plant knowledge is imperative to industry success, and budtending is the best way to familiarize yourself with the plant, the science behind it, and the industry as a whole. If you’ve ever found yourself googling “how to become a budtender”, you’ve come to the right article. 

As the cannabis industry continues to expand across the country and throughout the world, more people are interested in getting involved and innovating from behind the scenes.

Keep ReadingShow less
Battle over cannabis licenses in NY intensifies; MSO's Seek to Join Veterans Lawsuit
Battle over cannabis licenses in NY intensifies; MSO's Seek to Join Veterans Lawsuit

Battle Over Cannabis Licenses in New York Intensifies; MSOs Seek to Join Veterans Lawsuit

This story has been updated on Friday, August 11, 2023.

The landscape of New York's cannabis industry has been further convoluted by the entrance of powerful Multi-State Operators (MSOs) into the legal fray. The Coalition for Access to Regulated & Safe Cannabis (CARSC), a trade organization backed by prominent MSOs including Acreage Holdings, Curaleaf, Green Thumb Industries, and PharmaCann, has inserted itself into the recently filed lawsuit against the Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB) from four veterans who are claiming the CAURD program is unconstitutional. 

Keep ReadingShow less
New York's cannabis potency tax could cause all sorts of headaches.
New York's cannabis potency tax could cause all sorts of headaches.

Could New York’s Cannabis Potency Tax Ruin the State's Weed Industry?

New York’s legal cannabis retail sector is slowly taking shape after some major setbacks.

In late December, the state’s first legal adult-use dispensary opened for business and appears to be thriving.

Keep ReadingShow less